Nadine McGrath is a journalist at various esteemed publications including The Australian and The Daily Telegraph. She specializes in finance and healthcare, with a focus on markets, biotech, and social issues, exploring themes such as alternative medicine and diagnostics. Nadine's work has been featured in outlets like whimn.com.au, Geelong Advertiser, and Stockhead.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)
Not enough data
Nadine's focus on investment analysis and press releases indicates that she is likely to respond well to pitches offering unique insights into stock market trends, particularly within the healthcare and pharmaceutical industries. She may also be interested in receiving data-driven analyses or exclusive information related to ASX-listed companies.
Given her coverage of sales & marketing themes, Nadine might also appreciate pitches that provide in-depth analysis of marketing strategies or sales performance within the sectors she covers.
Since her geographic focus is national (Australia), sources with a deep understanding of this market and its specific dynamics would be most relevant for outreach.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Sonic Healthcare to buy LADR – Laboratory Group Dr. Kramer & Colleagues in Germany for ~A$700 million
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 26 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock pick.
By: Nadine Mcgrath
Welcome to Tru Datt, a Stockhead exclusive featuring the insights and opportunities of Emanuel Datt – founder and chief investment officer at Datt Capital, a Melbourne-based investment manager focused on identifying growth and special situation investments.
Private credit, also known as private debt, has evolved as a significant asset class and is set to continue its strong growth trajectory in 2025, according to experts in the sector
Private credit to continue strong growth trajectory in 2025, experts say Pallas Capital says established private credit managers are attracting institutional investors
By: Nadine Mcgrath
Percheron fell ~90% in a week Morgans analyst Scott Power described as one of both good and bad news for the ASX healthcare sector.
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 26 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock pick.
Check out the latest Interest Rates news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Morgans sees opportunities among several ASX healthcare stocks in 2025 Broker looking at stocks with near-term catalysts or sold down with good entry opportunities
Morgans healthcare and life sciences experts Iain Wilkie and Scott Power give Stockhead readers their top picks for 2025.
(833) 317-6278 
